Peterlabs Holdings Bhd (XKLS:0171) Liabilities-to-Assets : 0.31 (As of Jun. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XKLS:0171 Peterlabs Holdings Bhd XKLS:0171
47 GF Score
Price RM0.24
View Full Analysis

What is Peterlabs Holdings Bhd Liabilities-to-Assets?

Peterlabs Holdings Bhd XKLS:0171 +2.17% 47 Liabilities-to-Assets is 0.31 as of Jun. 2025. GuruFocus rates XKLS:0171 with a GF Score™ of 47/100.

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities, calculated as total liabilities divided by total asset. Peterlabs Holdings Bhd's Total Liabilities for the quarter that ended in Jun. 2025 was RM34.9 Mil. Peterlabs Holdings Bhd's Total Assets for the quarter that ended in Jun. 2025 was RM112.2 Mil. Therefore, Peterlabs Holdings Bhd's Liabilities-to-Assets Ratio for the quarter that ended in Jun. 2025 was 0.31.


Peterlabs Holdings Bhd  (XKLS:0171) Liabilities-to-Assets Explanation

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities. It can vary greatly across different industries, as they have different capital structure. A high Liabilities-to-Assets ratio (more leveraged) suggests that the company might have potential solvency problems, or even a signal of financial distress. Conversely, a low Liabilities-to-Assets ratio usually indicates a healthy financial situation. However, it may also suggest that the company is not expanding or not making good use of debt.


Peterlabs Holdings Bhd Liabilities-to-Assets Related Terms


Peterlabs Holdings Bhd Liabilities-to-Assets Historical Data

* Premium members only.

The historical data trend for Peterlabs Holdings Bhd's Liabilities-to-Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Peterlabs Holdings Bhd Liabilities-to-Assets Chart

Peterlabs Holdings Bhd Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Liabilities-to-Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.28 0.21 0.34 0.28 0.32

Peterlabs Holdings Bhd Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25
Liabilities-to-Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.33 0.29 0.32 0.27 0.31

XKLS:0171 vs ZTS, UTHR, VTRS: Liabilities-to-Assets Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Peterlabs Holdings Bhd's Liabilities-to-Assets, along with its competitors' market caps and Liabilities-to-Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Peterlabs Holdings Bhd Liabilities-to-Assets vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Peterlabs Holdings Bhd's Liabilities-to-Assets distribution charts can be found below:

* The bar in red indicates where Peterlabs Holdings Bhd's Liabilities-to-Assets falls into.


XKLS:0171
47GF Score
Peterlabs Holdings Bhd XKLS:0171
Liabilities-to-Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Peterlabs Holdings Bhd Liabilities-to-Assets Calculation

Liabilities-to-Assets ratio measures the portion of the total liabilities to the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Liabilities-to-Assets ratio is calculated by dividing total liabilities by total asset.

Peterlabs Holdings Bhd's Liabilities-to-Assets Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Liabilities-to-Assets (A: Dec. 2023 )=Total Liabilities/Total Assets
=37.992/118.395
=0.32

Peterlabs Holdings Bhd's Liabilities-to-Assets Ratio for the quarter that ended in Jun. 2025 is calculated as

Liabilities-to-Assets (Q: Jun. 2025 )=Total Liabilities/Total Assets
=34.905/112.152
=0.31

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Liabilities-to-Assets →
What does a Liabilities-to-Assets of 0.31 mean?
Peterlabs Holdings Bhd (XKLS:0171) has a Liabilities-to-Assets of 0.31 as of Jun. 2025. Liabilities-to-Assets equals total liabilities divided by total assets. It measures financial leverage. View historical data on Peterlabs Holdings Bhd and its competitors.
Is Peterlabs Holdings Bhd's Liabilities-to-Assets too high?
Peterlabs Holdings Bhd's current Liabilities-to-Assets is 0.31. Overall, Peterlabs Holdings Bhd has a GF Score™ of 47/100, reflecting its overall financial health beyond just this single metric.
How does Peterlabs Holdings Bhd's Liabilities-to-Assets compare to ZTS and UTHR?
Peterlabs Holdings Bhd's Liabilities-to-Assets of 0.31 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Liabilities-to-Assets for a Drug Manufacturers company?
A good Liabilities-to-Assets depends on the Drug Manufacturers industry context. However, Liabilities-to-Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Liabilities-to-Assets mean?
A high Liabilities-to-Assets can signal that a stock is expensive relative to its fundamentals. Liabilities-to-Assets equals total liabilities divided by total assets. It measures financial leverage. View historical data on Peterlabs Holdings Bhd and its competitors. Peterlabs Holdings Bhd's current Liabilities-to-Assets is 0.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Peterlabs Holdings Bhd stock overvalued right now?
Peterlabs Holdings Bhd (XKLS:0171) has a current Liabilities-to-Assets of 0.31. The current Liabilities-to-Assets is 0.31. Peterlabs Holdings Bhd's overall GF Score™ is 47/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Liabilities-to-Assets calculated?
Liabilities-to-Assets is calculated from a company's financial statements. For Peterlabs Holdings Bhd (XKLS:0171), the current Liabilities-to-Assets is 0.31 as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Peterlabs Holdings Bhd Business Description

Address Jalan Nilam 3, Lot 16014 (PT No. 24341), Bandar Nilai Utama, Nilai, NSN, MYS, 71800
Peterlabs Holdings Bhd is engaged in the manufacturing, distribution, export, and trading of animal health and nutrition products. The Group offers biosecurity and disinfectants, compound feed supplements, feed additives, nutritional premixes, pharmaceuticals, and water-soluble supplements, as well as farm management, technical advisory services, raw material analysis, and feed formulation. Its segments are Manufacturing, which covers the manufacturing and distribution of animal health and nutrition products; Trading, which involves the trading and distribution of animal health and nutrition products and consumer goods, and contributes the majority of its revenue; and Others, which provides investment holding services. The company operates in Malaysia and internationally.
47GF Score

Get the complete analysis for XKLS:0171

Liabilities-to-Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM0.24
Price